74.31MMarket Cap-641P/E (TTM)
4.9900High4.5600Low71.16KVolume4.8800Open4.8800Pre Close337.32KTurnover0.53%Turnover RatioLossP/E (Static)15.23MShares11.100052wk High1.20P/B65.88MFloat Cap2.235052wk Low--Dividend TTM13.50MShs Float242.0000Historical High--Div YieldTTM8.81%Amplitude2.2350Historical Low4.7400Avg Price1Lot Size
Affimed NV Stock Forum
NEWS
Affimed Announces Acceptance of AFM24 Clinical Abstract at the 2024 Annual Meeting of the American Society of Clinical Oncology
Affimed N.V. (Nasdaq: AFMD) announces the acceptance of the AFM24 clinical abstract at the 2024 ASCO Annual Meeting. The phase 2 study on AFM24 in combination with atezolizumab in patients with EGFR wild-type non-small cell lung cancer has been accepted for poster presentation. The abstract will be available on ASCO's website on May 23, 2024.
Updated Complete & Utter M&A Guesses Purely for Entertainment Purposes:
$Merck & Co(MRK.US)$ x $Immunovant(IMVT.US)$
$Eli Lilly and Co(LLY.US)$ x $Cytokinetics(CYTK.US)$ (and soon)
$Regeneron Pharmaceuticals(REGN.US)$ x $Apellis Pharmaceuticals(APLS.US)$ (panache & brash)
$Gilead Sciences(GILD.US)$ x %$Madrigal Pharmaceuticals(MDGL.US)$ (liver king)
$Bristol-Myers Squibb(BMY.US)$ x $Iovance Biotherapeutics(IOVA.US)$ (cell Tx boost needed)
$Eli Lilly and Co(LLY.US)$ x $Merus(MRUS.US)$ (partner n...
1:10 RS set for Monday 3/11/24
Dump the Junk
Update
Entered... like the bounce and chart!!
🧐
@OBIfromMEM
No comment yet